
Medimerz Pharma Private Limited
About Medimerz Pharma Private Limited
Data last updated:
Medimerz Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24234TG2012PTC082093. Its GSTIN is 18AAICM1608B1ZV (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Shyam Bhattar and Sushil Bhattar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 8 – 1/4 Ravindra Nagar Street No 8 Habsiguda, Hyderabad, Telangana, India – 500007.
The company has about 2 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Medimerz Pharma has one previous CIN (Corporate Identification Number): U24234AP2012PTC082093. The current CIN is U24234TG2012PTC082093, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24234TG2012PTC082093 | Current |
| U24234AP2012PTC082093 | Previous |
Contact details
Medimerz Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 – 8 – 1/4 Ravindra Nagar Street No 8 Habsiguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medimerz Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medimerz Pharma Private Limited
FY 2025 filings availableMedimerz Pharma Private Limited reported revenue of ₹3,503 (down 99% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 79% over five years, including a 99% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medimerz Pharma Private Limited, buy the company report.
Board of directors of Medimerz Pharma Private Limited
Medimerz Pharma has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Bhattar | Director | 09 Aug 2012 | 14 Years 3 Months | Current |
| Sushil Bhattar | Director | 09 Aug 2012 | 14 Years 3 Months | Current |
| Kishan Bhattar | Director | 09 Aug 2012 | 14 Years 3 Months | Current |
| Pawan Bhattar Also directs: Haleness Disposable Products LLP | Director | 09 Aug 2012 | 14 Years 3 Months | Current |
| Ram Bhattar | Director | 09 Aug 2012 | 14 Years 3 Months | Current |
Peer comparison
Medimerz Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VRG Biopharma Private Limited | ₹4,343 (FY 2025) | Hyderabad, Telangana, India | ||||
| Smart Mediscience Private Limited | ₹4,110 (FY 2025) | -100.0% | Jaipur, Rajasthan, India | |||
| Baijnath Distributors Private Limited | ₹3,686 (FY 2025) | -84.0% | Patna, Bihar, India | |||
| Medimerz Pharma Private Limitedthis company | ₹3,503 (FY 2024) | -99.0% | 2 | Hyderabad, Telangana, India | ||
| Anv Pharmacy Private Limited | ₹3,405 (FY 2025) | 5.0% | Gurgaon, Haryana, India | |||
| J4serv Private Limited | ₹3,335 (FY 2024) | -100.0% | Delhi, India | |||
| Vipul Drugs Private Limited | ₹3,130 (FY 2024) | 1336.0% | Mumbai, Maharashtra, India | |||
| El-Life Medi Pharma Limited | ₹3,000 (FY 2019) | -100.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Medimerz Pharma Private Limited, buy the company report.
Auditor
Medimerz Pharma Private Limited is audited by Bikash Laxmi & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bikash Laxmi & Associates | FY 2023 | 060403 |
Shareholding
The shareholding of Medimerz Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medimerz Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medimerz Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medimerz Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medimerz Pharma Private Limited has a workforce of 2 employees on its EPFO records as of Jul 2022, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2022-23 | 2 |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Medimerz Pharma Private Limited, buy the company report.
GST
Medimerz Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAICM1608B1ZV | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medimerz Pharma Private Limited, buy the company report.
Recent activity
Medimerz Pharma Private Limited has 8 board changes on record since 2012: 5 appointments and 3 cessations. The latest: Nemichand Bhatter ceased to be Director on 15 Jun 2022.
Frequently asked questions
Medimerz Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2012 (14+ years old) and is registered under CIN U24234TG2012PTC082093.
Medimerz Pharma has 5 current directors:
- Shyam Bhattar - Director
- Sushil Bhattar - Director
- Kishan Bhattar - Director
- Pawan Bhattar - Director
- Ram Bhattar - Director
The latest financial statements of Medimerz Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medimerz Pharma is 18AAICM1608B1ZV, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Medimerz Pharma is U24234TG2012PTC082093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medimerz Pharma was incorporated on 20 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Medimerz Pharma by revenue are VRG Biopharma Private Limited, Smart Mediscience Private Limited, Baijnath Distributors Private Limited, Anv Pharmacy Private Limited, J4serv Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Nemichand Bhatter ceased to be Director on 15 Jun 2022. Anupam Dey ceased to be Director on 20 May 2019. Gopal Bhattar ceased to be Director on 09 Aug 2012. Medimerz Pharma has 8 board changes on record in total.
The registered office of Medimerz Pharma is at 1 – 8 – 14 Ravindra Nagar Street No 8 Habsiguda, Hyderabad, Telangana, India – 500007.
Medimerz Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Medimerz Pharma is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.

